Research Support Services for Impact of Rare Diseases on Patients and Healthcare Systems (IDeaS) Initiative

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.The solicitation number is 75N95021Q00316 and the solicitation is issued as a request for quotation (RFQ).This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; FAR Subpart 13.5— Simplified Procedures for Certain Commercial Items; and FAR Part 12—Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold. The Government anticipates award of a firm fixed-price contract for this acquisition, and the anticipated award date is September 29, 2021.The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2021-07 dated September 10, 2021.This acquisition is full and open with no set-aside restrictions. The associated NAICS code is 541611, Administrative Management and General Management Consulting Services, and the small business size standard is $16.5 million.Combined Synopsis/Solicitation Number 75N95021Q00316 is attached in full text along with its seven (7) Solicitation Attachments.Statement of Need and Purpose: The National Center for Advancing Translational Sciences (NCATS) Office of Rare Diseases Research (ORDR) is seeking support services to enable the generation of independent analyses, computational tools, and methodologies on the prevalence, clinical course, cost, and utilization impact of patients with rare diseases, that leverage large healthcare systems databases and data sources.The Statement of Work (SOW) is included as Attachment